Investor News & Updates

two people talking in front of bayer logo

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 443 News
1 - 10of 443 News
October 30, 2025
PCB litigation: Washington Supreme Court ruling in Erickson
READ MORE
October 24, 2025
Not intended for U.S. and UK Media
Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
READ MORE
September 22, 2025
Not intended for US and UK Media
Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease
READ MORE
September 18, 2025
Not intended for U.S. and UK Media
New drug application for gadoquatrane accepted for review in China
READ MORE
August 30, 2025
Not intended for U.S. and UK Media
Data from Phase III VICTOR clinical trial of vericiguat presented at ESC Congress 2025
READ MORE
August 18, 2025
Monsanto reaches agreements in principle to resolve additional PCB cases at the Sky Valley Education Center
READ MORE
August 06, 2025
Bayer posts positive second quarter and progress on strategic priorities
READ MORE
July 31, 2025
Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States
READ MORE
July 30, 2025
Bayer submits registration applications for novel herbicide in four major markets
READ MORE
July 25, 2025
Not intended for U.S. and UK Media
Bayer provides regulatory update on elinzanetant in the U.S.
READ MORE
1 - 10of 443 News
1 - 10of 443 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more